Related Experiment Video
Updated: Nov 22, 2025
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing
Filip A Dąbrowski1, Nikodem Sadlik2, Krzysztof Nowosielski3
11st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland; Club 35. Polish Society of Gynecologists and Obstetricians, Poland.
Introduction And Importance:
Case report of patient with congenital lack of factor VII, suffering from recurrent hematomas and massive menstrual bleedings resulting in severe anemia and multiple hospitalization.
Case Presentation:
Patient was diagnosed with endometrial hyperplasia and not responding to hormonal treatment and substitution with recombinant factor VII was not effective to reduce the bleedings. This case describes successful laparoscopic technique of using bipolar coagulation and non-absorbable clips.
Clinical Discussion:
We describe premedication and post-surgical management - which we had to modify from this found in very scarce literature. Despite previous vaginal deliveries without any complications during the puerperium, 20 days after the surgery patient presented with intraperitoneal bleeding after stopping rFVIIa therapy. It was treated medically without the need for re-laparoscopy.
Conclusion:
Laparoscopic surgery is possible in patients with lack and deficiency of FVIIa, but they need close post-operative surveillance and prolonged supplementation with recombinant FVIIa.
